Health Care Equipment & Services

Labcorp’s Q4 2026 earnings show steady growth, AI‑powered specialty testing and a strong outlook, positioning the diagnostics leader for future value‑based care expansion.

EssilorLuxottica’s modest share rise on Feb 16, 2026, signals strong market confidence, while its own‑share transaction hints at value creation amid expected European easing.

Discover how Straumann Holding AG’s February earnings reveal the future of global dental‑implant markets, spotlighting supply‑chain risks, regulatory shifts, and digital‑dental opportunities for investors.

Discover how IDEXX Laboratories is driving companion‑animal diagnostics forward with AI, automation, and rapid point‑of‑care tools, expanding globally to boost lab efficiency and investor confidence.

EssilorLuxottica’s new share‑buyback signals confidence, while its cutting‑edge lens tech and strict safety compliance promise sustained growth in the global eyewear market.

Smith & Ne­phew plc’s rising share price reflects solid orthopaedic & wound‑care growth, a strong safety record, and a pipeline of proven, cost‑effective products.

Discover why Sonova Holding AG remains a top Swiss equity pick—robust growth, low risk, and a cutting‑edge hearing‑aid pipeline set to outperform peers.

Abbott Laboratories’ diversified portfolio—from drugs to diagnostics—offers balanced growth amid shifting healthcare spending and digital health trends. Learn how cross‑segment synergies keep the stock steady yet poised for future gains.

Terumo Corporation reports modest Q4 2026 revenue growth, slight EPS dip, and strong transfusion/infusion sales—positioning it to capture rising peripheral vascular device demand.

Medtronic PLC eyes earnings growth with new Indian campaign and leadership in embolic protection and CSF devices, boosting investor confidence and market reach.